Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments ...

is an injectable anti-diabetic treatment that became wildly popular on social networks for its slimming properties. Novo Nordisk launched the anti-obesity drug Wegovy in the United States in 2021.

While a smattering of media reports shows thieves are after Ozempic elsewhere in the world Brazil has become a prime global hot spot for criminals coveting the hugely popular weight-loss drugs.

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

The long-acting injectable once-a-month Fanapt is evaluated ... in the prevention of vomiting induced by a GLP-1 analog, Wegovy, that is semaglutide in the fourth quarter of 2024.

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.